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HR each contributed significantly to the improvement in EF observed with chronic O- 
blocker treatment. Reverse remodeling (i.e., decreased end-diastolic volume) is not a 
major factor. 
Adjusted Estimates of Percentage Surviving 
9:oo a.m. 
874-3 Predictors of Mortality in Patients With Heart Failure 
and Preserved Systolic Function in the Digitalis 
Investigation Group Trial 
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R. Christopher Jones, Eugene H. Blackstone. Gary S. Francis, Michael S. Lauer, The 
Cleveland Clinic Foundation, Cleveland, OH 
9:30 a.m. 
Background: Although diastolic heart failure is common, the factors that predict mortal- 
sty have not been clearly defined. 
Methods: We studied 988 patients (59% men) with documented heart failure and ejec- 
tion fraction > 45% who were enrolled and prospectively followed in the Digitalis Investi- 
gation Group (DIG) trial. During 3.1 years of follow-up, there were 231 deaths (23%). 
Results: The average age was 87210 years, and the average ejection fraction was 
Ss+_S%. There were 285 patients with diabetes (29%) and 557 with fschemlc head dis- 
ease (57%). In univariable analyses, predictors of death included older age, increasing 
serum creatinine, decreasing body mass index, and presence of diabetes (Figure shows 
quartiles or presence of these versus 3-year Kaplan-M&r death rates). 
874-5 Improvement in Global and Segmental Left Ventricular 
Contractility Following Autologous Bone Marrow Cell 
Transplantation in Humans With Severe lschemic Heart 
Failure 
Emerson C. Penn, Hans F. Dohmann, Radovan Borojevic, Hans J. Dohmann, Antonio C. 
Carvalho, Yong J. Geng, Andre Luiz S. Sousa, Guilherme V. Silva, Fernando Rangel, 
Swarm A. Silva, Isabel Rossi, Roberto Esporcatte, James T. WilIerson, Texas Head 
Institute, Houston, TX, Hospital Pro-Cardiaco, Rio de Janew Brazil 
Backgrounci Limited treatment options exist for pts with end-stage ischemic heart fail- 
ure (HF) notamenable to revascularization. We evaluated the effect of transendwardial 
(TE) delivery of autologous bone marrow mononuclear cells (BMNC) in pts with severe 
HF. 
Gender, ejection fraction, and etiology of heart failure were not predictors of death. In 
stepwise multivariable Cox regression analyses that considered 20 covariates. indepen- 
dent predictors of death were increasing creatinine (score 2 = 88, P < O.OOOl), NYHA 
class (f = 25, P < 0.0001). recent worsening heart failure (x2 = 12, P = 0.0005), older 
age (x2 = 10, P = 0.0017), body mass index (x2 = 4, P = 0.038), diabetes (x2 = 5. P = 
0.023). and use of diuretics (x2 = 4, P = 0.038). 
Conclusions: Diastolic heart failure is associated with a high death rate. Important pre- 
dictors of death include age, renal function, functional class, body mass index, and dia- 
betes. 
9:15 a.m. 
874-4 Assessment of Long-Term Outcome in a Population at 
High Risk for Coronary Artery Disease: Mortality Risk 
Associated With Ejection Fraction Differs Across 
Resting Nuclear Perfusion Findings 
Jam&on M. Bouraue. Linda K. Shaw, Eric J. Velazquez, Christopher M. O’Connor, 
Salvador Barges-Neto, Duke University Medical Center, Durham, NC 
Background: Resting myocardial perfusion studies assess myocardial viability in 
patients with heart failure. The sum rest score (SRS), a marker for perfusion abnormality 
severity at rest, provides independent prognostic information for patients at low to inter- 
mediate risk for coronary artery disease (CAD). However, its prognostic role and poten- 
tial interaction with ejection fraction (EF) in a high risk population are less well defined. 
Methods: We examined 3,275 patients at high risk for CAD who underwent cardiac cath- 
eterization and nuclear imaging within a six month interval and were followed up to 8 
years. We used Cox proportional hazards modeling to assess the relationship between 
EF and SRS after adjusting for significant clinical characteristics. 
Results: A significant interaction (p=O.O30) was found between the nuclear SRS and EF. 
Each 10% decrease in EF for patients with a low risk SRS of 1 provided a 29% increase 
m mortality risk (p=O.OOl, hazard ratio (HR) =1.29. 95% confidence interval (Cl) 1.19- 
1.40). while those wth a hfgh risk SRS of 8 (cohort 75” percentile) had a 37% increase 
(p=O.OOl, HR 1.37, 95% Cl 1.23-l .52). Adjusted survival estimates across SRS levels 
and EF groups were obsewed (see table). 
Conclusion: Resting perfusion studies significantly Impact the interpretation of mortality 
risk associated with changes in resting EF. This clinical interaction should be taken into 
account when nuclear perfusion imagmg is performed to assess prognosis and viability in 
the low EF populabon. 
Methods Ten pts (58 f 11 yrs, 7 males) with severe LV dysfunction (EF 19 + 10 %) and 
were included. Bone marrow (50ml) was aspirated and BMNCs were isolated. TE injec- 
tions were performed using the Myo-Star catheter (NOGA, Biosense) to target hibemat- 
ing myocardium guided by electromechanical mapping (EMM). Pts were evaluated by 
a)angiography (LVEF) b) EMM (mean values of linear local shortening (LLS) and unlpo- 
lar voltage (UniV)) and c)echo (wall motion score index). LVEF and treated vs. non- 
treated segments were analyzed before and 18 wks after the procedure. Student’s paired 
T-test was utilized. 
Resultr On angiography LVEF increased from 19*9% to 24~12% (p=O.O05). A total of 
18 myocardial segments were injected (2kO.7 per pt). On EMM the mean LLS values in 
the treated areas increased from 5.7*3.7% to 10.8*3.5 % (p=O.O05) UniV values of the 
treated segments did not vary significantly after cell therapy (from 10.5 r 3.5 to 10.3 * 2.7 
mV; p=O.8). 
By echocardiography the wall motion score index decreased from 2.0 * 0.7 to 1.8 * 0.8 
(p=O.OOOS) in the treated segments and from 1.9*0.3 to 1.7r0.2 (p=O.Ol) in the non- 
treated segments. 
Conclusion In this small number of pts there was an overall lmprovent in LVEF by 
angiography following TE injection of BMNC at 18wk follow-up. There was improvement 
in segmental contractility in the treated areas by both echocardiographic and EMM crite- 
ria. Future studies are needed to further clarify the role of stem-cell therapy m the treat- 
ment of severe HF. 
9:45 a.m. 
874-6 The Association of Left Ventricular Ejection Fraction, 
Mortality, and Cause of Death in Stable Patients With 
Heart Failure 
Jeptha P. Cur&., Seth I. Sokol. Yongfei Wang, Saif S. Rathote, Dennis T. Ko, Farid 
Jadbabaie, Edward L. Portnay, Stephen J. Marshalko, Martha J. Radford, Harlan M. 
Krumholz, Yale University School of Medicine, New Haven, CT 
Background Left ventricular ejection fraction (LVEF) IS used as a predictor of prognosis 
in heart failure (HF) patients. but the manner in which the associatton of LVEF, mortality, 
and cause of death vanes across the full spectrum of LVEF is incompletely understood. 
Methods and Results: We examined the association of LVEF and outcomes in 7788 
patients enrolled in the Digitalis Investigation Group trial. With mean follow-up of 37 
months, mortality was substantial in all LVEF groups (range LVER15%: 51.7%, >55: 
23.5%). Among pabents with LVEK45%. mortality rates decreased in a near linear fash- 
ion across successively higher LVEF groups (LVEM15%: 51.7%; LVEF 38-45%. 25.8%; 
PcO.OOl), but mortality was comparable in LVEF groups above 45% (LVEF 48.55%: 
23.3%, LVEF>55%: 23.5%; P=O.25). In multivariable analysis, the magnitude of the 
association was reduced (LVERlS%: HR 1.84. Cl 1.54-2.18; 18-25%: HR 1.47, Cl 1.30. 
1.85; 28.35%: HR 1.13, Cl 1.01.1’.28; 38-45%: referent; 48-55%: HR 0.91, Cl 0.78-1.09; 
~-55%: HR 0.89, Cl 0.71-l .lO). Patients with lower LVEF were at increased risk of death 
due to arrhythmia and worsening HF, but these wars leading causes of death in all LVEF 
groups. 
Conclusions Annual mortality was more than 5.5% in all LVEF groups, but lower LVEF 
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was associated with increased mortality only among HF patients with LVEF @5%. 
Deaths due to arrhythmias and worsening HF contribute to the substantial mortality of 
patients wth LVEF>45% and may be targets for future interventions in this population. 
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In multlvarlate models, both LAD and LAVI remained independent predictors of stroke. 
LAVI (x2= 9.3, p=O.O02) was a powerful predictor, independent of age (x2=6.2. p=O.O13) 
and TIA k2=9.1, p=O.O02), adjusted for sex, hypertension, DM, and MI. A significant 
increment in risk (~~0.05) was found from quartile 1 to 2 of LAVI, and further from quartile 
3 to 4, while an increment in stroke risk was observed only from quartile 3 to 4 for LAD. 
Conclusions: LAVI is a powerful independent predictor of first stroke in older adults. It 
appears to be superior to LAD in the discrimination of stroke risk, even among the lower 
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887FO-2 The Modifying Effect of Age on Risk Factors for Stroke: 
The Manitoba Follow-Up Study 
T. E. Cuddy, Robert B. Tate, Dennis J. Bayomi, T. K. Young, University of Manitoba. 
Winnipeg, MB, Canada 
Background: The Manitoba Follow-up Study, initiated in 1946, is a prospective investiga- 
tion of cardiovascular disease in a cohort of 3,963 men. The present investigation is the 
effect of age on traditional risk factors for stroke. 
Methods: Over a 50 year follow-up period physical examinations including blood pres- 
sure measurements and electrocardiograms have been recorded. Selected measure- 
ments from examinations at 5 year age intervals between 30 and 70 years of age for 
each man were related to the incidence of definite stroke and to all cerebrovascular 
events (definite stroke plus transient ischemic attacks) using Cox proportional hazard 
models (p-value set at 0.05 for risk factors). 
Results: During 163,933 person years of observation, a total of 552 men experienced 
cerebrovascular events, including 316 men with definite strokes. Across ages from 30 to 
70 years, significant risk ratios for definite stroke associated with a 10 mm Hg difference 
in SBP ranoed between 1.16 to 1.29 and between 1.26 to 1.50 for the same chanae in 
DBP. Risk ratios for diabetes mellitus ranged between 1.61 to 3.40, between 2.24 to3.11 
for atnal fibrillation and from a10 down to 1.56 for prior evidence of IHD. The nsk ratios 
for BPS were greatest between age 45 and 55 years. Age specific risk ratios were greater 
in models for definite strokes than in models for all cerebrovascular events. While the 
effects of these tradltional risk factors: blood pressure, atrial fibrillation and prior IHD 
decline in magnitude with age, the effect of smoking did not significantly vary with age, 
and remained statistically significant to age 70 years with risk ratios in the range of 1.46 
to 1.94. Body mass index, at any age, was not significantly associated with stroke. 
Conclusions: Recognition of the varying effect of these risk factors with age is important 
in the Identification of men at high risk for stroke. 
11:OOa.m. 
887FO-3 Prediction of First Stroke in Older Men and Women 
Without Atrial Fibrillation or Valvular Heart Disease 
Teresa S. Tsanq. Marion E. Barnes, Kent R. Bailey, James B. Seward, Mayo Clinic, 
Rochester. MN 
Background: Stroke is a major cause of disability and mortality in the elderly Accurate 
risk stratification is pivotal for containment of this major public health problem. 
Methods: The study included residents of Olmsted County, Minnesota, who underwent 
echocardiography between 1990-96 and at the time were t 65 years of age, in sinus 
rhythm, without valvular or congenital heart disease, prior stroke or atria.1 fibrillation. Clin- 
ical and echocardiographic characteristics were retneved from medical records. Left 
atrial volume, indexed to body surface area (LAVI) was measured offline. Multwarlate 
Cox propoftional hazards models for prediction of stroke were developed. The relative 
hazards associated with successively higher quartiles of age-adjusted left atrial dimen- 
sion (LAD) and LAVl were determined with Cox proportional hazards modeling, starting 
with a ‘saturated model’ and an assumption that a change in risk occurred with each 
quartile increment. The least significant jumps wars deleted in succession until all terms 
were significant at p ~0.05. 
Results: Amongst 1459 patients (mean age 75+7 years; 38% male) who met the study 
criteria, incident stroke occurred in 102 patients (7%) over mean follow-up time of 4.2 * 
3.6 years. Univariate predictors of stroke were age, hypertension, heart failure, myocar- 
dial infarction (Ml), diabetes mellitus (DM), carotid artery disease, transient ischemic 
attack (TIA), LAVI. LAD, left ventricular (LV) wall thickness, and LV fractlonal shortening. 
887FO-4 Platelet Function in the Elderly: The Difference Between 
Stable and Unstable Angina 
John R. Gilstad, Ross E. Anderson, Kewn P. Bliden, Paul A. Gurbel, Sinai Center for 
Thrombosis Research, Baltimore, MD, Johns Hopkins University School of Medicme, 
Baltimore, MD 
Background: The functional status of platelets in older patients with acute coronary syn- 
dromes (ACS) may be reduced, in contrast to increased platelet activity seen in stable 
older subjects. Methods: Platelet functional status was assessed using light-transmlt- 
tance aggregometry with ADP and flow cytometric assay of platelet surface membrane 
markers in 55 patients presenting with ACS and 41 patients presenting with stable 
angina each of whom had demographic and medication data recorded. Multiple regres- 
sion analysis on each platelet function variable was used to define independent predic- 
tors. Results: Patients ranged in age from 38 to 92 years with a mean of 66. Aggregation 
was found to decrease with advancing age, but only among the ACS patients. In multi- 
variate analysis. age was the best predictor of decreased aggregation (Beta = -.556, 12 
=.353, p<O.OOl) among the patients with ACS Age was also the best predicator of 
decline in platelet labeling with PAC.I, an antibody against the GP llbillla active site 
(Beta=-,561, r2=.276, p=<.OOl) and of decline in platelet surface P-selectin (Beta=-,442, 
r2=240, p=<.OOl). Age did not predict total GPllblllla expression in either ACS or stable 
patients, nor platelet-leukocyte aggregates (co-labeling with antibody to CD 151 and CD 
14). Conclusion: In older patients with ACS there is decreased platelet actiwty at pre- 
sentation, indicated by an age-related decrease in ADP aggregation and decreased 
platelet surface expression of the active conformation of GPllb/llla and P-selectin. The 
absence of an age-related decrease in expression of total GPllblllla, and of platelet-leu- 
kocyte aggregates, suggests a complex interaction between age and platelet physiology. 
Decreased activation of GPllb/llla in older patients with ACS may relate to the observed 
increase in hemorrhagic complications in the elderly following llbillla inhibitors therapy, 
as well as thrombolytic therapy, and suggests a rationale for age-adjusting the dosage of 
these drugs. 
11:30 a.m. 
887FO-5 Reduced Aortic Distensibility and Congestive Heart 
Failure Among the Elderly in a Population-Based Study: 
The Cardiovascular Health Study 
Dalane W. Kitzman, John S. Gottdiener. Gerard P Aurigemma, Alice M. Arnold, Cheryl 
Egher. Karen Fowls, Jeffrey C. Hill, Wake Forest University School of Medicine, Winston 
Salem, NC, St. Francis Hospital, New York, NY 
Background: Thoracic aortic distensibility (AOD) decreases with aging and is a major 
determinant of left ventricular &e&ad. Several lines of ewdence suggest that an exag- 
gerated reduction in AOD may play a role in heart failure (HF) in the elderly, the malority 
of whom have preserved systolic function. Methods: We examined AOD by echocardio- 
graphy in a case-control analysis of 657 participants (pts) (438 HF pts and 419 controls) 
in the population-based Cardiovascular Health Study. Results: pts were 76*6 years old 
(range 66-99), and 52% were women. Age-adjusted mean (+ se) AOD was 1.30 X 10-3 
(* 0.12 X 10-3) mmHg-1 in normal pts without cardiovascular disease (CVD). 1.02 x IO-3 
(+ 0.08 X 10-3) in pts with subclinical CVD, 0.83 x 10-3 (i 0.14 X 10-3) rn pts with estab- 
lished CVD but not HF, and 0.77 x 10-3 (+ 0.06 X 10-3) in pts with HF (p<O.OOl, differ- 
ence acmss groups). Thus, there was a stepwise decrease in a&c distensibility with 
increasmg CV disease burden. The reduction in AOD was similar in HF pts with pre- 
served vs. reduced systolic function. Reduced AOD was significantly associated with 
prevalent HF (at the time of the echo) and was a significant predictor of the development 
of incident HF over 3 years of follow-up (odds ratio 1.3 per std dev for both, confidence 
llmlts 1 .1-l .5, p <O.Ol, adjusted for age and gender). When the components of AOD 
were examined in paired analysis models, phasic aoltlc change yielded information 
regarding HF that was independent of pulse pressure. Conclusion: Aortic distensibility is 
reduced among elderly pts with either diastolic HF or systolic HF and is a significant prs- 
dictor of incident HF. Aortic stiffening may play a role in the development of HF I” the eld- 
erly. 
11:45 a.m. 
887FO-8 Elderly Patients Have Better Functioning, Less Angina 
at One Year With Coronary Artery Bypass Graft 
Karen P. Alexander, Barbara Lyile, Yun LI, Eric Peterson, Duke Clinical Research 
Institute. Durham, NC 
Background: Elderly pts facing CABG or PCI are concerned with quality as well as 
quantity of life. Yet, there is limited empirical data regarding longitudinal functional out- 
comes in elderly pts. 
Methods: We evaluated 1,058 pts aged > 70 yrs (mean 76 yrs) with significant CAD at 
cardiac catheterization from 8/98 to 4/ 01 at Duke. We compared baseline and 1 yr status 
